Botensilimab
Botensilimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Botensilimab is under investigation in clinical trial NCT03860272 (Fc-engineered Anti-ctla-4 Monoclonal Antibody in Advanced Cancer).
| Trade Name | Botensilimab |
| Generic | Botensilimab |
| Botensilimab Other Names | Botensilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Botensilimab
